StratifAI’s Post

Our latest research featured on the Oncology Learning Network! 🎤 In this interview, our CEO Omar El Nahhas speaks about StratifAI BReast (SAIBR), a novel AI-based prognostication method predicting long-term progression-free survival in HR+/HER2- early breast cancer. 🧬 Our exciting results were accepted as late-breaking abstract at #SABCS2024. However, this is just the beginning - we are initially developing these tools in breast cancer, but are expanding to other solid tumor cancers to improve prognostication and help steer better treatment decisions, worldwide! 🌍💜 Check the video in the link below. 👇 https://lnkd.in/gZ2W4kdY

Novel AI-Based Prognostication Method Predicts Long-Term Progression-Free Survival in HR-Positive, HER2-Negative Early Breast Cancer

Novel AI-Based Prognostication Method Predicts Long-Term Progression-Free Survival in HR-Positive, HER2-Negative Early Breast Cancer

hmpgloballearningnetwork.com

Arpit Aggarwal

PhD Candidate at Georgia Tech and Emory University | AI in Healthcare | Digital Pathology

5d

Amazing work! Thanks for sharing!

To view or add a comment, sign in

Explore topics